What is NVO's current stock price?

As of now, NVO is trading at $50.30, with a daily change of -14.64%.

What are the risks associated with NVO stock?

NVO has Low, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO

Novo Nordisk A/S

$50.30

-$8.63 | -14.64%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$93.8

MKT CAP

$171.31B

52W Low

$43.08

VOL

$63.85M

P/E Ratio

13.65

AVG VOL

$21.32M

RSI

35.29

TREND

Sideways

NVO Stock IQ

Login to see Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

NVO Target Price

Login to display

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

NVO Price Performance

$55.11 (-8.73%)

$48.46 (+3.80%)

$54.3 (-7.37%)

$82.33 (-38.90%)

1year

6month

3month

1month

NVO Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

NVO Analysts Opinion

NVO Analysts opinion is negative and it remained unchanged from the past 3 months

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

47%

69%

NVO Street Sentiment

NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVO Risk Level

NVO has Low risk level

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Performance Sentiment

Sentiments overview associated with events and the stock performance

72%

22%

Positive

Negative

62 out of 86
events present

19 out of 86
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$59.43

Resistance
Price

$51.61

Current Price Range

$63.98

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

5

0

Date

Action

Rating

Firm

Jan 10, 2026

Initiate

Outperform

CICC

Dec 16, 2025

Upgrade

Buy

BERENBERG

Nov 29, 2025

Reiterate

Buy

Goldman Sachs

Nov 25, 2025

Initiate

Overweight

Nov 20, 2025

Reiterate

Buy

Linked to NVO

Close Price

Change

LLY

Eli Lilly and

1003.46

-3.90%

PFE

Pfizer

25.77

-3.34%

LEXX

Lexaria Bioscience

0.77

-3.31%

VKTX

Viking Therapeutics

29.41

-1.70%

SNY

Sanofi

47.49

+0.47%

Recently Viewed

Close Price

Change

HLIT

Harmonic

9.84

-1.30%

NVO

Novo Nordisk A/S

50.30

-14.64%

HLI

Houlihan Lokey

164.45

-2.32%

FWONK

Liberty Media Corporation

85.77

+0.32%

COE

51Talk Online Education

26.75

+0.94%

NVO Latest Analysis +

Novo Nordisk falls after 2025 results dragging Lilly (update).

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Crashes After Projecting 2026 Decline. Surprising With Day-Early Report. Novo Nordisk stock crashed Tuesday after the company said it expects sales and operating profit to decline by 5% to 13% this year.The post Novo Crashes After Projecting 2026 Decline. Surprising With Day-Early Report appeared first on Investor'.s Business Daily.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Nordisk Stock Falls As 2026 Outlook Signals Pricing Pressure Slowing Sales. ) stock is trading lower on Tuesday after the weight-loss drug maker released its 2026 full-year sales and operating profit outlook.Novo Nordisk reported 2026 sales and operating profit to benefit from a $4.2 billion reversal of 340B Drug Pricing Program in the United States In 2025 $400 million was excluded.Excluding this one-time item the mid-point of sales and operating profit growth guidance for 2026 both at CE

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Potential

Novo Nordisk shares tumble after company warns of sales hit this year. The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key United States market.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Nordisk shares plunge on weak 2026 sales outlook.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Potential

Novo Nordisk reports mixed results for 2025.

Tue Feb 3, 2026

$50.30 | -14.64%

Earnings

Novo Nordisk Says CagriSema Shows Superior HbA1c Reduction Weight Loss In REIMAGINE 2 Trial . (RTTNews) - Danish drug maker Novo Nordisk A/S (NVO NOVOB.CO NOV.DE) announced late Monday headline results from REIMAGINE 2 trial in which CagriSema demonstrated both superior HbA1c reduction and weight loss at week 68 versus semaglutide across all tested doses in adults wit

Tue Feb 3, 2026

$50.30 | -14.64%

Activity

Potential

Jim Cramer Believes Novo Nordisk Is a Hold Not a Buy. Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer shared his thoughts on. The first caller of the episode inquired about the stock and Cramer replied: I kind of liked it when I spoke to them. I gotta tell you I kind of warmed up I was in San Francisco and I said [….]

Mon Feb 2, 2026

$58.93 | -0.86%

Potential

Is Novo Nordisk Stock a Bargain Right Now?. Key PointsNovo Nordisk was a leader in GLP-1 weight loss but was displaced by Eli Lilly.

Mon Feb 2, 2026

$58.93 | -0.86%

Potential

Demand for Novo Nordisks Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally?. Key PointsNovo Nordisk obtained approval for its GLP-1 weight loss pill late last year.

Fri Jan 30, 2026

$59.43 | +0.17%

Activity

Momentum

FAQ About NVO Stock Insights

What is NVO current stock price?

What are NVO stock strengths?

What is NVO Risk Level?

What is NVO market cap and volume?

What is NVO current Stock IQ?

Should I buy NVO stock right now?

Is NVO a Strong Buy right now?

What does a 'Strong Buy' rating mean for NVO?

What does a 'Strong Sell' rating mean for NVO?

What factors influence NVO's Stock IQ?

Explore our NVO Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored NVO Stock Strategies
Effective Risk Management

FIND US ON

Receive our NVO Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

NVO

Novo Nordisk A/S

Set Alerts

Current Price

$50.30

-$8.63 | -14.64%

52W High

$93.8

MKT CAP

$171.31B

52W Low

$43.08

VOL

$63.85M

P/E Ratio

13.65

AVG VOL

$21.32M

RSI

35.29

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Linked to NVO

Symbol

Close

Change

LLY

Eli Lilly and

1003.46

-3.90%

PFE

Pfizer

25.77

-3.34%

LEXX

Lexaria Bioscience

0.77

-3.31%

VKTX

Viking Therapeutics

29.41

-1.70%

SNY

Sanofi

47.49

+0.47%

NVO Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

72%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

47%

69%

NVO Street Sentiment

NVO Street Sentiment is extremely bullish and have positive views on the near-term outlook

NVO Risk Level

NVO has Low risk level

Risks Indicators

Investors losing confidence

Hit 52-week low

Low

LOW

HIGH

NVO Performance Sentiment

Sentiments overview associated with events and the stock performance.

72%

22%

Positive

Negative

62 out of 86
events present

19 out of 86
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$59.43

Resistance
Price

$51.61

Current Price Range

$63.98

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

5

0

Date

Action

Rating

Firm

Jan 10, 2026

Initiate

Outperform

CICC

Dec 16, 2025

Upgrade

Buy

BERENBERG

Nov 29, 2025

Reiterate

Buy

Goldman Sachs

Nov 25, 2025

Initiate

Overweight

Nov 20, 2025

Reiterate

Buy

NVO Stock IQ

Login to unlock Novo Nordisk A/S (NVO) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

NVO Rewards

Earnings are forecast to grow

NVO Rewards

Trading below its fair value

NVO Rewards

Upgraded on attractively valued

NVO Rewards

Investors confidence is positive

NVO Latest Analysis

Novo Nordisk falls after 2025 results dragging Lilly (update).

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Crashes After Projecting 2026 Decline. Surprising With Day-Early Report. Novo Nordisk stock crashed Tuesday after the company said it expects sales and operating profit to decline by 5% to 13% this year.The post Novo Crashes After Projecting 2026 Decline. Surprising With Day-Early Report appeared first on Investor'.s Business Daily.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Nordisk Stock Falls As 2026 Outlook Signals Pricing Pressure Slowing Sales. ) stock is trading lower on Tuesday after the weight-loss drug maker released its 2026 full-year sales and operating profit outlook.Novo Nordisk reported 2026 sales and operating profit to benefit from a $4.2 billion reversal of 340B Drug Pricing Program in the United States In 2025 $400 million was excluded.Excluding this one-time item the mid-point of sales and operating profit growth guidance for 2026 both at CE

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Potential

Novo Nordisk shares tumble after company warns of sales hit this year. The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key United States market.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Novo Nordisk shares plunge on weak 2026 sales outlook.

Tue Feb 3, 2026

$50.30 | -14.64%

Momentum

Potential

Novo Nordisk reports mixed results for 2025.

Tue Feb 3, 2026

$50.30 | -14.64%

Earnings

Novo Nordisk Says CagriSema Shows Superior HbA1c Reduction Weight Loss In REIMAGINE 2 Trial . (RTTNews) - Danish drug maker Novo Nordisk A/S (NVO NOVOB.CO NOV.DE) announced late Monday headline results from REIMAGINE 2 trial in which CagriSema demonstrated both superior HbA1c reduction and weight loss at week 68 versus semaglutide across all tested doses in adults wit

Tue Feb 3, 2026

$50.30 | -14.64%

Activity

Potential

Jim Cramer Believes Novo Nordisk Is a Hold Not a Buy. Novo Nordisk A/S (NYSE:NVO) is one of the stocks Jim Cramer shared his thoughts on. The first caller of the episode inquired about the stock and Cramer replied: I kind of liked it when I spoke to them. I gotta tell you I kind of warmed up I was in San Francisco and I said [….]

Mon Feb 2, 2026

$58.93 | -0.86%

Potential

Is Novo Nordisk Stock a Bargain Right Now?. Key PointsNovo Nordisk was a leader in GLP-1 weight loss but was displaced by Eli Lilly.

Mon Feb 2, 2026

$58.93 | -0.86%

Potential

Demand for Novo Nordisks Weight Loss Pill Is Strong Out of the Gate. Is the Stock Due for a Big Rally?. Key PointsNovo Nordisk obtained approval for its GLP-1 weight loss pill late last year.

Fri Jan 30, 2026

$59.43 | +0.17%

Activity

Momentum

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVO. We're here to help you make informed investment decisions today.

FIND US ON

Receive our NVO Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

NVO Stock trends

NVO Stock performance

NVO Stock analysis

NVO investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing NVO

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

NVO Stock Analysis & IQ Rating | Novo Nordisk A/S

NVO Stock IQ

NVO Target Price

NVO Analysts Opinion

NVO Street Sentiment

NVO Risk Level

NVO Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our NVO Stock insights

Receive our NVO Daily Alerts

NVO Street Sentiment

NVO Risk Level

Key Price Levels

Latest Analyst Actions

Discover NVO Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of NVO. We're here to help you make informed investment decisions today.

Receive our NVO Daily Alerts

NVO Alerts